0000059478-20-000086.txt : 20200331 0000059478-20-000086.hdr.sgml : 20200331 20200331115040 ACCESSION NUMBER: 0000059478-20-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200330 FILED AS OF DATE: 20200331 DATE AS OF CHANGE: 20200331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fry Stephen F CENTRAL INDEX KEY: 0001513324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 20760479 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 wf-form4_158566982249782.xml FORM 4 X0306 4 2020-03-30 0 0000059478 ELI LILLY & Co LLY 0001513324 Fry Stephen F LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 SVP, HR & Diversity Common Stock 2020-03-30 4 S 0 11500 133.82 D 110572 D Common Stock 2020-03-30 4 S 0 1658 135.31 D 108914 D Common Stock 2020-03-30 4 S 0 615 136.34 D 108299 D Common Stock 2020-03-30 4 S 0 884 137.23 D 107415 D Common Stock 176 I 401(k) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2020. This transaction was executed in multiple trades at prices ranging from $133.76 to $134.59. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $134.85 to $135.66. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $135.90 to $136.59. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $136.88 to $137.50. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Crystal T. Williams for Stephen F. Fry, authorization on file 2020-03-30 EX-24 2 frypoa.htm FRY_POA

Stephen F. Fry
Lilly Corporate Center
Indianapolis, Indiana  46285



Securities and Exchange Commission
Washington, D.C.  20549

Authorization Regarding Reporting Forms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5(including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

    Anat Hakim, Lilly Corporate Center, Indianapolis, Indiana

    Bronwen L. Mantlo, Lilly Corporate Center, Indianapolis, Indiana

    Crystal T. Williams, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.


Date: February 27, 2020



/s/ Stephen F. Fry